REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Elanda Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Fats and Oils Refining and Blending | Coffee and Tea Manufacturing | All Other Food Manufacturing | Toilet Preparation Manufacturing | General Line Grocery Merchant Wholesalers | Other Grocery and Related Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Elanda Pharma Sp. z o.o. Profile Updated: July 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Elanda Pharma Sp. z o.o. is an enterprise located in Poland, with the main office in Rozprza. It operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on August 10, 2018. It currently has a total number of 11 - 50 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 10.6% in 2025. Over the same period, its total assets grew by 11.61%.

Headquarters
Ul. Sportowa 9
Rozprza; Lodzkie; Postal Code: 97-340

Contact Details: Purchase the Elanda Pharma Sp. z o.o. report to view the information.

Website: http://www.elanda.pl

Basic Information
Total Employees:
Purchase the Elanda Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Elanda Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Elanda Pharma Sp. z o.o. report to view the information.
Incorporation Date:
August 10, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Elanda Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
10.6%▲
Total Operating Revenue
10.77%▲
Operating Profit
N/A
EBITDA
112.05%▲
Net Profit/Loss for the Period
N/A
Total Assets
11.61%▲
Total Equity
19.24%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-9.86%▼
Quick Ratio
0.25%▲
Cash Ratio
0.12%▲

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
Lek S.A.
Teva Operations Poland Sp. z o.o.
 
Adamed Pharma S.A.
Aflofarm Farmacja Polska Sp. z o.o.
 
"Fresenius Kabi Polska" Sp. z o.o.
"Gryfarm" Sp. z o.o.
 
Fidia Pharma Polska Sp. z o.o.
Laboratorium Farmaceutyczne Avena Sp. z o.o.
 
Nutrition Health Institute Sp. z o.o.
Almirall Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo